EVH vs. WSC, HNGE, RELY, DLO, APLD, CARG, ATHM, TNET, CNXC, and YY
Should you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include WillScot (WSC), Hinge Health (HNGE), Remitly Global (RELY), DLocal (DLO), Applied Digital (APLD), CarGurus (CARG), Autohome (ATHM), TriNet Group (TNET), Concentrix (CNXC), and JOYY (YY). These companies are all part of the "business services" industry.
Evolent Health vs. Its Competitors
Evolent Health (NYSE:EVH) and WillScot (NASDAQ:WSC) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.
95.8% of WillScot shares are owned by institutional investors. 1.4% of Evolent Health shares are owned by company insiders. Comparatively, 3.1% of WillScot shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Evolent Health has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500. Comparatively, WillScot has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500.
In the previous week, Evolent Health and Evolent Health both had 13 articles in the media. WillScot's average media sentiment score of 1.43 beat Evolent Health's score of 0.69 indicating that WillScot is being referred to more favorably in the news media.
WillScot has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than WillScot, indicating that it is currently the more affordable of the two stocks.
WillScot has a net margin of 4.66% compared to Evolent Health's net margin of -5.94%. WillScot's return on equity of 24.83% beat Evolent Health's return on equity.
Evolent Health currently has a consensus target price of $17.43, indicating a potential upside of 87.40%. WillScot has a consensus target price of $36.00, indicating a potential upside of 52.93%. Given Evolent Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Evolent Health is more favorable than WillScot.
Summary
WillScot beats Evolent Health on 12 of the 16 factors compared between the two stocks.
Get Evolent Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evolent Health Competitors List
Related Companies and Tools
This page (NYSE:EVH) was last updated on 9/12/2025 by MarketBeat.com Staff
Free EVH Stock Alerts